Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	5/8/2006 8:18:16 AM
	of 10280

Sepracor initiated with "hold" -update- Monday, May 08, 2006 4:43:24 AM ET A.G. Edwards & Sons NEW YORK, May 8 (newratings.com) - Analyst Aaron S Reames of AG Edwards initiates coverage of Sepracor Inc (SEPR.NAS) with a "hold" rating. The fair value is set to $44. In a research note published on May 4, the analyst mentions that the company has three approved products, including Lucenta and Xopenex. Sepracor is expected to become profitable this year without requiring additional financing, the analyst says. On the other hand, the company is facing stiff competition across all sectors and may require increasing marketing expenditures to effectively compete, since the market share growth for Xopenex and Lunesta is likely to slow in 2006, AG Edwards adds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next